Quantification of rifampicin and rifabutin in plasma of tuberculosis patients by micellar liquid chromatography
NAGIOS: RODERIC FUNCIONANDO

Quantification of rifampicin and rifabutin in plasma of tuberculosis patients by micellar liquid chromatography

DSpace Repository

IMPORTANT: El repositori està en manteniment des del dia 28 de Novembre fins al 3 de Desembre, només es pot consultar, però no afegir contingut. Disculpeu les molèsties

Quantification of rifampicin and rifabutin in plasma of tuberculosis patients by micellar liquid chromatography

Show simple item record

dc.contributor.author Goberna Bravo, María Ángeles
dc.contributor.author Peris Vicente, Juan
dc.contributor.author Esteve i Romero, Josep-Salvador
dc.contributor.author Mishra, Pooja
dc.contributor.author Albiol-Chiva, Jaume
dc.date.accessioned 2023-11-20T14:52:34Z
dc.date.available 2023-11-20T14:52:34Z
dc.date.issued 2020
dc.identifier.uri https://hdl.handle.net/10550/91262
dc.description.abstract A Micellar Liquid Chromatographic method is described to determine Rifampicin and Rifabutin in plasma from Tuberculosis patients. Samples were diluted in mobile phase and then directly injected, avoiding long and tedious extraction steps. The analytes were resolved from the matrix without interferences from endogenous compounds using a mobile phase of sodium dodecyl sulfate 0.15 mol L-1-6%(v/v) 1-pentanol and phosphate buffer at pH 3, running at 1 mL min−1 through a C18 column at 25 °C. Detection was carried out by UV absorbance at 270 nm. Under these conditions, the final chromatographic analysis time was 22 min. The analytical methodology was validated following the FDA 2018 Bioanalytical Method Validation Guidance for Industry. The response of the drugs in plasma was linear in the 0.05-5 μg/mL range, with r2 > 0.9993. Trueness and precision were <14% for both substances. Carry over and matrix effects were negligible. Dilution integrity, robustness and stability were also investigated. Method was reliable, economic, eco-friendly, safe, easy-to-conduct, and with a high sample throughput, thus useful for routine analysis. Finally, the analytical method was used to determine both antituberculosis drugs in incurred plasma samples of Tuberculosis patients.
dc.language.iso eng
dc.relation.ispartof Microchemical Journal, 2020, vol. 157, p. 104865
dc.source Goberna Bravo, María Ángeles, Peris Vicente, Juan, Esteve i Romero, Josep-Salvador, Mishra, Pooja, Albiol-Chiva, Jaume (2020). Quantification of rifampicin and rifabutin in plasma of tuberculosis patients by micellar liquid chromatography. Microchemical Journal, 157 104865. https://doi.org/10.1016/j.microc.2020.104865
dc.subject tuberculosi
dc.subject plasma (gasos ionitzats)
dc.subject química analítica
dc.title Quantification of rifampicin and rifabutin in plasma of tuberculosis patients by micellar liquid chromatography
dc.type journal article
dc.date.updated 2023-11-20T14:52:34Z
dc.identifier.doi 10.1016/j.microc.2020.104865
dc.identifier.idgrec 139729
dc.rights.accessRights open access

View       (229.8Kb)

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search

Browse

Statistics